Scholarly Commons at Boston University School of Lawmetadata only
Evaluating For-Profit Public Benefit Corporations as an Additional Structure for Antibiotic Development and Commercialization
companies, public, antibiotics, antibiotic, market, commercial, research, therapeutics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 328020
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.